Sequenom
About:
Sequenom provides genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders.
Website: https://womenshealth.labcorp.com
Twitter/X: sequenomlabs
Top Investors: National Institutes of Health
Description:
Sequenom offers genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders. The company provides a nucleic acid analysis platform that measures genetic target material and variations.
Total Funding Amount:
$185M
Estimated Revenue Range:
$100M to $500M
Headquarters Location:
San Diego, California, United States
Founded Date:
1994-01-01
Contact Email:
info(AT)sequenom.com
Founders:
Charles Cantor, Hubert Koster
Number of Employees:
501-1000
Last Funding Date:
2012-09-24
IPO Status:
Delisted
Industries:
© 2025 bioDAO.ai